Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediumBank is an international leader in high-end chemically defined cell culture media R&D and manufacturing. Its catalog includes standard and custom solutions validated by over 600+ biopharmaceutical companies globally. The company’s offerings support all stages from R&D to clinical filings to commercial production. It has achieved ISO13485 certification and completed DMF filings for key products such as MaxFA/FB dual feed medium.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai MediumBank Biotechnology.